GLI1 and melanoma: Indeed, our data showed that chemical targeting of SMO and GLI1 can impair CAXII expression and melanoma migration and invasion, highlighting, in this experimental model, the possibility to develop small molecules that are more effective in reducing melanoma aggressiveness.